BackCatabasis Pharmaceuticals Overview

Catabasis Pharmaceuticals Current Cash

Latest current cash for CATB: $96M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$96.28M

Peer trimmed avg / median

Loading

Catabasis Pharmaceuticals Current Cash History

Loading

Catabasis Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Catabasis Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Catabasis Pharmaceuticals (CATB) FAQ

As of the most recent data (September 2025), CATB shows a current cash of $96M. Scroll down for historical charts and peer comparison views.

Tracking CATB's current cash over time shows whether Catabasis Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $96M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Catabasis Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $96M) with ownership activity and broader fundamentals.

Catabasis Pharmaceuticals's current cash is $96M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.